Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Iridex (IRIX) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Iridex (IRIX) over the last 17 years, with Q3 2025 value amounting to $5.4 million.

  • Iridex's Operating Expenses fell 1241.72% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year decrease of 2455.61%. This contributed to the annual value of $27.8 million for FY2024, which is 1260.45% down from last year.
  • Per Iridex's latest filing, its Operating Expenses stood at $5.4 million for Q3 2025, which was down 1241.72% from $5.6 million recorded in Q2 2025.
  • In the past 5 years, Iridex's Operating Expenses ranged from a high of $14.1 million in Q1 2022 and a low of $5.3 million during Q1 2025
  • In the last 5 years, Iridex's Operating Expenses had a median value of $7.8 million in 2024 and averaged $7.6 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 4434.55% in 2021, then plummeted by 4275.79% in 2022.
  • Quarter analysis of 5 years shows Iridex's Operating Expenses stood at $7.9 million in 2021, then increased by 1.7% to $8.1 million in 2022, then fell by 1.34% to $8.0 million in 2023, then decreased by 23.58% to $6.1 million in 2024, then decreased by 10.91% to $5.4 million in 2025.
  • Its Operating Expenses was $5.4 million in Q3 2025, compared to $5.6 million in Q2 2025 and $5.3 million in Q1 2025.